Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Molecular Neurodegeneration
Published in: Molecular Neurodegeneration 1/2011

Open Access 01-12-2011 | Review

Biology and pathophysiology of the amyloid precursor protein

Authors: Hui Zheng, Edward H Koo

Published in: Molecular Neurodegeneration | Issue 1/2011

Login to get access

Abstract

The amyloid precursor protein (APP) plays a central role in the pathophysiology of Alzheimer's disease in large part due to the sequential proteolytic cleavages that result in the generation of β-amyloid peptides (Aβ). Not surprisingly, the biological properties of APP have also been the subject of great interest and intense investigations. Since our 2006 review, the body of literature on APP continues to expand, thereby offering further insights into the biochemical, cellular and functional properties of this interesting molecule. Sophisticated mouse models have been created to allow in vivo examination of cell type-specific functions of APP together with the many functional domains. This review provides an overview and update on our current understanding of the pathobiology of APP.
Appendix
Available only for authorised users
Literature
1.
Daigle I, Li C: apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor. Proc Natl Acad Sci USA. 1993, 90 (24): 12045-9. 10.1073/pnas.90.24.12045.PubMedPubMedCentral
2.
Rosen DR, et al: A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor. Proc Natl Acad Sci USA. 1989, 86 (7): 2478-82. 10.1073/pnas.86.7.2478.PubMedPubMedCentral
3.
Luo L, Tully T, White K: Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene. Neuron. 1992, 9 (4): 595-605. 10.1016/0896-6273(92)90024-8.PubMed
4.
Musa A, Lehrach H, Russo VA: Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev Genes Evol. 2001, 211 (11): 563-7. 10.1007/s00427-001-0189-9.PubMed
5.
Okado H, Okamoto H: A Xenopus homologue of the human beta-amyloid precursor protein: developmental regulation of its gene expression. Biochem Biophys Res Commun. 1992, 189 (3): 1561-8. 10.1016/0006-291X(92)90254-I.PubMed
6.
van den Hurk WH, Bloemen M, Martens GJ: Expression of the gene encoding the beta-amyloid precursor protein APP in Xenopus laevis. Brain Res Mol Brain Res. 2001, 97 (1): 13-20.PubMed
7.
Goldgaber D, et al: Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 1987, 235 (4791): 877-80. 10.1126/science.3810169.PubMed
8.
Tanzi RE, et al: Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 1987, 235 (4791): 880-4. 10.1126/science.2949367.PubMed
9.
Wasco W, et al: Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor. Proc Natl Acad Sci USA. 1992, 89 (22): 10758-62. 10.1073/pnas.89.22.10758.PubMedPubMedCentral
10.
Wasco W, et al: Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid beta protein precursor. Nat Genet. 1993, 5 (1): 95-100. 10.1038/ng0993-95.PubMed
11.
Slunt HH, et al: Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). J Biol Chem. 1994, 269 (4): 2637-44.PubMed
12.
Collin RW, et al: Identification and expression of the first nonmammalian amyloid-beta precursor-like protein APLP2 in the amphibian Xenopus laevis. Eur J Biochem. 2004, 271 (10): 1906-12. 10.1111/j.1432-1033.2004.04100.x.PubMed
13.
Martin-Morris LE, White K: The Drosophila transcript encoded by the beta-amyloid protein precursor-like gene is restricted to the nervous system. Development. 1990, 110 (1): 185-95.PubMed
14.
Yoshikai S, et al: Genomic organization of the human amyloid beta-protein precursor gene [published erratum appears in Gene 1991 Jun 30;102(2):291-2]. Gene. 1990, 87 (2): 257-63. 10.1016/0378-1119(90)90310-N.PubMed
15.
Lamb BT, et al: Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected] [published erratum appears in Nat Genet 1993 Nov;5(3):312]. Nat Genet. 1993, 5 (1): 22-30. 10.1038/ng0993-22.PubMed
16.
Sisodia SS, et al: Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci. 1993, 13 (7): 3136-42.PubMed
17.
Siman R, et al: Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron. 1989, 3 (3): 275-85. 10.1016/0896-6273(89)90252-3.PubMed
18.
Van Den Heuvel C, et al: Upregulation of amyloid precursor protein and its mRNA in an experimental model of paediatric head injury. J Clin Neurosci. 2000, 7 (2): 140-5. 10.1054/jocn.1999.0168.PubMed
19.
De Strooper B, Annaert W: Proteolytic processing and cell biological functions of the amyloid precursor protein [In Process Citation]. J Cell Sci. 2000, 113 (Pt 11): 1857-70.PubMed
20.
Vassar R, et al: Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999, 286 (5440): 735-41. 10.1126/science.286.5440.735.PubMed
21.
Yan R, et al: Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity [see comments]. Nature. 1999, 402 (6761): 533-7. 10.1038/990107.PubMed
22.
Sinha S, et al: Purification and cloning of amyloid precursor protein beta-secretase from human brain [see comments]. Nature. 1999, 402 (6761): 537-40. 10.1038/990114.PubMed
23.
Cai H, et al: BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 2001, 4 (3): 233-4. 10.1038/85064.PubMed
24.
Luo Y, et al: Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci. 2001, 4 (3): 231-2. 10.1038/85059.PubMed
25.
Huse JT, et al: Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J Biol Chem. 2002, 277 (18): 16278-84. 10.1074/jbc.M111141200.PubMed
26.
Solans A, Estivill X, de La Luna S: A new aspartyl protease on 21q22.3, BACE2, is highly similar to Alzheimer's amyloid precursor protein beta-secretase. Cytogenet Cell Genet. 2000, 89 (3-4): 177-84. 10.1159/000015608.PubMed
27.
Yan R, et al: BACE2 functions as an alternative alpha-secretase in cells. J Biol Chem. 2001, 276 (36): 34019-27. 10.1074/jbc.M105583200.PubMed
28.
Hook V, et al: Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease. Biol Chem. 2005, 386 (9): 931-40. 10.1515/BC.2005.108.PubMed
29.
Hook VY, Kindy M, Hook G: Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008, 283 (12): 7745-53. 10.1074/jbc.M708362200.PubMed
30.
Roberds SL, et al: BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet. 2001, 10 (12): 1317-24. 10.1093/hmg/10.12.1317.PubMed
31.
Lichtenthaler SF: Alpha-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J Neurochem. 116 (1): 10-21.
32.
Buxbaum JD, et al: Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem. 1998, 273 (43): 27765-7. 10.1074/jbc.273.43.27765.PubMed
33.
Blacker M, et al: Effect of tumor necrosis factor-alpha converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons. J Neurochem. 2002, 83 (6): 1349-57. 10.1046/j.1471-4159.2002.01228.x.PubMed
34.
Kuhn PH, et al: ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 29 (17): 3020-32.
35.
Donmez G, et al: SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell. 142 (2): 320-32.
36.
Gowing E, et al: Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem. 1994, 269 (15): 10987-90.PubMed
37.
Lalowski M, et al: The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid. J Biol Chem. 1996, 271 (52): 33623-31. 10.1074/jbc.271.52.33623.PubMed
38.
Tekirian TL, et al: N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. J Neuropathol Exp Neurol. 1998, 57 (1): 76-94. 10.1097/00005072-199801000-00009.PubMed
39.
Wei W, et al: Abeta 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis. Brain. 2002, 125 (Pt 9): 2036-43.PubMed
40.
Szczepanik AM, Rampe D, Ringheim GE: Amyloid-beta peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J Neurochem. 2001, 77 (1): 304-17. 10.1046/j.1471-4159.2001.t01-1-00240.x.PubMed
41.
Edbauer D, et al: Reconstitution of gamma-secretase activity. Nat Cell Biol. 2003, 5 (5): 486-8. 10.1038/ncb960.PubMed
42.
Iwatsubo T: The gamma-secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol. 2004, 14 (3): 379-83. 10.1016/j.conb.2004.05.010.PubMed
43.
Wolfe MS, et al: Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity [In Process Citation]. Nature. 1999, 398 (6727): 513-7. 10.1038/19077.PubMed
44.
Ahn K, et al: Activation and intrinsic {gamma}-secretase activity of presenilin 1. Proc Natl Acad Sci USA. 2010, 107 (50): 21435-40. 10.1073/pnas.1013246107.PubMedPubMedCentral
45.
Zhao G, et al: Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein. J Biol Chem. 2004, 279 (49): 50647-50. 10.1074/jbc.C400473200.PubMed
46.
Zhao G, et al: {gamma}-Cleavage Is Dependent on {zeta}-Cleavage during the Proteolytic Processing of Amyloid Precursor Protein within Its Transmembrane Domain. J Biol Chem. 2005, 280 (45): 37689-97. 10.1074/jbc.M507993200. Epub 2005 Sep 12PubMed
47.
Sato T, et al: Blocking the cleavage at midportion between gamma- and epsilon-sites remarkably suppresses the generation of amyloid beta-protein. FEBS Lett. 2005, 579 (13): 2907-12. 10.1016/j.febslet.2005.04.037.PubMed
48.
Sastre M, et al: Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2001, 2 (9): 835-41. 10.1093/embo-reports/kve180.PubMedPubMedCentral
49.
Weidemann A, et al: A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry. 2002, 41 (8): 2825-35. 10.1021/bi015794o.PubMed
50.
Qi-Takahara Y, et al: Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J Neurosci. 2005, 25 (2): 436-45. 10.1523/JNEUROSCI.1575-04.2005.PubMed
51.
Yagishita S, et al: Abeta46 is processed to Abeta40 and Abeta43, but not to Abeta42, in the low density membrane domains. J Biol Chem. 2008, 283 (2): 733-8.PubMed
52.
Yagishita S, et al: DAPT-Induced Intracellular Accumulations of Longer Amyloid beta-Proteins: Further Implications for the Mechanism of Intramembrane Cleavage by gamma-Secretase. Biochemistry. 2006, 45 (12): 3952-60. 10.1021/bi0521846.PubMed
53.
Takami M, et al: gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci. 2009, 29 (41): 13042-52. 10.1523/JNEUROSCI.2362-09.2009.PubMed
54.
Annaert WG, Saftig p: Regulated intramembrane proteolysis--a story about sheddases and I-CliPs. Semin Cell Dev Biol. 2009, 20 (2): 125-10.1016/j.semcdb.2009.03.005.PubMed
55.
Hu X, et al: Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006, 9 (12): 1520-5. 10.1038/nn1797. Epub 2006 Nov 12PubMed
56.
Willem M, et al: Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 2006, 314 (5799): 664-6. 10.1126/science.1132341. Epub 2006 Sep 21PubMed
57.
Wolfe MS, Kopan R: Intramembrane proteolysis: theme and variations. Science. 2004, 305 (5687): 1119-23. 10.1126/science.1096187.PubMed
58.
Kopan R, Ilagan MX: Gamma-secretase: proteasome of the membrane?. Nat Rev Mol Cell Biol. 2004, 5 (6): 499-504. 10.1038/nrm1406.PubMed
59.
Selkoe D, Kopan R: Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 2003, 26: 565-97. 10.1146/annurev.neuro.26.041002.131334.PubMed
60.
Lorenzo A, et al: Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease. Nat Neurosci. 2000, 3 (5): 460-4. 10.1038/74833.PubMed
61.
Lu DC, et al: Amyloid beta protein toxicity mediated by the formation of amyloid-beta protein precursor complexes. Ann Neurol. 2003, 54 (6): 781-9. 10.1002/ana.10761.PubMed
62.
Ho A, Sudhof TC: Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Natl Acad Sci USA. 2004, 101 (8): 2548-53. 10.1073/pnas.0308655100.PubMedPubMedCentral
63.
Park JH, et al: Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci. 2006, 26 (5): 1386-95. 10.1523/JNEUROSCI.3291-05.2006.PubMedPubMedCentral
64.
Lourenco FC, et al: Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production. Cell Death & Differentiation. 2009, 16 (5): 655-63. 10.1038/cdd.2008.191.
65.
Matsuda S, et al: Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Neurobiol Aging. 2009
66.
Giliberto L, et al: Generation and initial characterization of FDD knock in mice. PLoS One. 2009, 4 (11): e7900-10.1371/journal.pone.0007900.PubMedPubMedCentral
67.
Small DH, et al: Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. J Alzheimers Dis. 1999, 1 (4-5): 275-85.PubMed
68.
Wang Y, Ha Y: The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain. Mol Cell. 2004, 15 (3): 343-53. 10.1016/j.molcel.2004.06.037.PubMed
69.
Soba P, et al: Homo- and heterodimerization of APP family members promotes intercellular adhesion. Embo J. 2005, 24 (20): 3624-34. 10.1038/sj.emboj.7600824. Epub 2005 Sep 29PubMedPubMedCentral
70.
Dahms SO, et al: Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein. Proc Natl Acad Sci USA. 2010, 107 (12): 5381-6. 10.1073/pnas.0911326107.PubMedPubMedCentral
71.
Munter LM, et al: GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42. EMBO Journal. 2007, 26 (6): 1702-12. 10.1038/sj.emboj.7601616.PubMedPubMedCentral
72.
Kienlen-Campard P, et al: Amyloidogenic processing but not amyloid precursor protein (APP) intracellular C-terminal domain production requires a precisely oriented APP dimer assembled by transmembrane GXXXG motifs. J Biol Chem. 2008, 283 (12): 7733-44. 10.1074/jbc.M707142200.PubMedPubMedCentral
73.
Eggert S, et al: Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production. J Biol Chem. 2009, 284 (42): 28943-52. 10.1074/jbc.M109.038646.PubMedPubMedCentral
74.
Kaden D, et al: Subcellular localization and dimerization of APLP1 are strikingly different from APP and APLP2. J Cell Sci. 2009, 122 (Pt 3): 368-77.PubMed
75.
Ghiso J, et al: A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion. Biochem J. 1992, 288 (Pt 3): 1053-9.PubMedPubMedCentral
76.
Storey E, et al: The amyloid precursor protein of Alzheimer's disease is found on the surface of static but not activity motile portions of neurites. Brain Res. 1996, 735 (1): 59-66. 10.1016/0006-8993(96)00609-9.PubMed
77.
Yamazaki T, Koo EH, Selkoe DJ: Cell surface amyloid beta-protein precursor colocalizes with beta 1 integrins at substrate contact sites in neural cells. J Neurosci. 1997, 17 (3): 1004-10.PubMed
78.
Young-Pearse TL, et al: Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev. 2008, 3: 15-10.1186/1749-8104-3-15.PubMedPubMedCentral
79.
Young-Pearse TL, et al: A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci. 2007, 27 (52): 14459-69. 10.1523/JNEUROSCI.4701-07.2007.PubMed
80.
Wang Z, et al: Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci. 2009, 29 (35): 10788-801. 10.1523/JNEUROSCI.2132-09.2009.PubMedPubMedCentral
81.
Scheiffele P, et al: Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell. 2000, 101 (6): 657-69. 10.1016/S0092-8674(00)80877-6.PubMed
82.
Graf ER, et al: Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell. 2004, 119 (7): 1013-26. 10.1016/j.cell.2004.11.035.PubMedPubMedCentral
83.
Biederer T, et al: SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science. 2002, 297 (5586): 1525-31. 10.1126/science.1072356.PubMed
84.
Fogel AI, et al: SynCAMs organize synapses through heterophilic adhesion. J Neurosci. 2007, 27 (46): 12516-30. 10.1523/JNEUROSCI.2739-07.2007.PubMed
85.
Sara Y, et al: Selective capability of SynCAM and neuroligin for functional synapse assembly. J Neurosci. 2005, 25 (1): 260-70. 10.1523/JNEUROSCI.3165-04.2005.PubMed
86.
Linhoff MW, et al: An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron. 2009, 61 (5): 734-49. 10.1016/j.neuron.2009.01.017.PubMedPubMedCentral
87.
Dalva MB, McClelland AC, Kayser MS: Cell adhesion molecules: signalling functions at the synapse. Nat Rev Neurosci. 2007, 8 (3): 206-20. Epub 2007 Feb 14PubMed
88.
Norstrom EM, et al: Identification of NEEP21 as a ss-amyloid precursor protein-interacting protein in vivo that modulates amyloidogenic processing in vitro. J Neurosci. 30 (46): 15677-85.
89.
Mattson MP: Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev. 1997, 77 (4): 1081-132.PubMed
90.
Reinhard C, Hebert SS, De Strooper B: The amyloid-beta precursor protein: integrating structure with biological function. Embo J. 2005, 24 (23): 3996-4006. 10.1038/sj.emboj.7600860. Epub 2005 Oct 27PubMedPubMedCentral
91.
Koo EH, et al: Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA. 1990, 87 (4): 1561-5. 10.1073/pnas.87.4.1561.PubMedPubMedCentral
92.
Yamazaki T, Selkoe DJ, Koo EH: Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J Cell Biol. 1995, 129 (2): 431-42. 10.1083/jcb.129.2.431.PubMed
93.
Lyckman AW, et al: Post-translational processing and turnover kinetics of presynaptically targeted amyloid precursor superfamily proteins in the central nervous system. J Biol Chem. 1998, 273 (18): 11100-6. 10.1074/jbc.273.18.11100.PubMed
94.
Moya KL, et al: The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev Biol. 1994, 161 (2): 597-603. 10.1006/dbio.1994.1055.PubMed
95.
Hung AY, et al: Increased expression of beta-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc Natl Acad Sci USA. 1992, 89 (20): 9439-43. 10.1073/pnas.89.20.9439.PubMedPubMedCentral
96.
Bibel M, et al: Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci. 2004, 7 (9): 1003-9. 10.1038/nn1301.PubMed
97.
Murakami N, et al: Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J Neurotrauma. 1998, 15 (11): 993-1003. 10.1089/neu.1998.15.993.PubMed
98.
Van den Heuvel C, et al: Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp Neurol. 1999, 159 (2): 441-50. 10.1006/exnr.1999.7150.PubMed
99.
Leyssen M, et al: Amyloid precursor protein promotes post-developmental neurite arborization in the Drosophila brain. Embo J. 2005, 24 (16): 2944-55. 10.1038/sj.emboj.7600757. Epub 2005 Jul 28PubMedPubMedCentral
100.
Rossjohn J, et al: Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol. 1999, 6 (4): 327-31. 10.1038/7562.PubMed
101.
Saitoh T, et al: Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell. 1989, 58 (4): 615-22. 10.1016/0092-8674(89)90096-2.PubMed
102.
Ninomiya H, et al: Amino acid sequence RERMS represents the active domain of amyloid beta/A4 protein precursor that promotes fibroblast growth. J Cell Biol. 1993, 121 (4): 879-86. 10.1083/jcb.121.4.879.PubMed
103.
Meziane H, et al: Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci USA. 1998, 95 (21): 12683-8. 10.1073/pnas.95.21.12683.PubMedPubMedCentral
104.
Roch JM, et al: Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor. Proc Natl Acad Sci USA. 1994, 91 (16): 7450-4. 10.1073/pnas.91.16.7450.PubMedPubMedCentral
105.
Thornton E, et al: Soluble amyloid precursor protein alpha reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats. Brain Res. 2006, 1094 (1): 38-46. 10.1016/j.brainres.2006.03.107.PubMed
106.
Copanaki E, et al: sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress. Mol Cell Neurosci. 2010, 44 (4): 386-93. 10.1016/j.mcn.2010.04.007.PubMed
107.
Allinquant B, et al: Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol. 1995, 128 (5): 919-27. 10.1083/jcb.128.5.919.PubMed
108.
Perez RG, et al: The beta-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J Neurosci. 1997, 17 (24): 9407-14.PubMed
109.
Herard AS, et al: siRNA targeted against amyloid precursor protein impairs synaptic activity in vivo. Neurobiol Aging. 2006, 27 (12): 1740-50. 10.1016/j.neurobiolaging.2005.10.020.PubMed
110.
Taylor CJ, et al: Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory. Neurobiol Dis. 2008, 31 (2): 250-60. 10.1016/j.nbd.2008.04.011.PubMed
111.
Han P, et al: Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation. J Neurosci. 2005, 25 (50): 11542-52. 10.1523/JNEUROSCI.3831-05.2005.PubMed
112.
Caille I, et al: Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development. 2004, 131 (9): 2173-81. 10.1242/dev.01103. Epub 2004 Apr 8PubMed
113.
Gakhar-Koppole N, et al: Activity requires soluble amyloid precursor protein alpha to promote neurite outgrowth in neural stem cell-derived neurons via activation of the MAPK pathway. Eur J Neurosci. 2008, 28 (5): 871-82. 10.1111/j.1460-9568.2008.06398.x.PubMed
114.
Bergmans BA, et al: Neurons generated from APP/APLP1/APLP2 triple knockout embryonic stem cells behave normally in vitro and in vivo: lack of evidence for a cell autonomous role of the amyloid precursor protein in neuronal differentiation. Stem Cells. 2010, 28 (3): 399-406.PubMed
115.
Naumann N, et al: Transgenic expression of human wild-type amyloid precursor protein decreases neurogenesis in the adult hippocampus. Hippocampus. 20 (8): 971-9.
116.
Li H, et al: Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc Natl Acad Sci USA. 107 (40): 17362-7.
117.
Schwarzman AL, et al: Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci USA. 1994, 91 (18): 8368-72. 10.1073/pnas.91.18.8368.PubMedPubMedCentral
118.
Choi SH, et al: Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). Journal of Neuroscience. 2007, 27 (26): 7006-10. 10.1523/JNEUROSCI.1919-07.2007.PubMed
119.
Buxbaum JN, et al: Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proceedings of the National Academy of Sciences of the United States of America. 2008, 105 (7): 2681-6. 10.1073/pnas.0712197105.PubMedPubMedCentral
120.
Kuro-o M, et al: Mutation of the mouse klotho gene leads to a syndrome resembling ageing.[see comment]. Nature. 1997, 390 (6655): 45-51. 10.1038/36285.PubMed
121.
Kurosu H, et al: Suppression of aging in mice by the hormone Klotho. Science. 2005, 309 (5742): 1829-33. 10.1126/science.1112766.PubMedPubMedCentral
122.
Imura A, et al: alpha-Klotho as a regulator of calcium homeostasis. Science. 2007, 316 (5831): 1615-8. 10.1126/science.1135901.PubMed
123.
Lannfelt L, et al: Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neurosci Lett. 1995, 199 (3): 203-6. 10.1016/0304-3940(95)12059-D.PubMed
124.
Sennvik K, et al: Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett. 2000, 278 (3): 169-72. 10.1016/S0304-3940(99)00929-5.PubMed
125.
Colciaghi F, et al: [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med. 2002, 8 (2): 67-74.PubMedPubMedCentral
126.
Tyler SJ, et al: alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun. 2002, 299 (3): 373-6. 10.1016/S0006-291X(02)02635-9.PubMed
127.
Roe CM, et al: Cancer linked to Alzheimer disease but not vascular dementia. Neurology. 74 (2): 106-12.
128.
Venkataramani V, et al: Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem. 285 (14): 10678-89.
129.
Turner PR, et al: Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol. 2003, 70 (1): 1-32. 10.1016/S0301-0082(03)00089-3.PubMed
130.
Nikolaev A, McLaughlin T, O'Leary DDM, Tessier-Lavigne M: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature. 2009, 457: 981-990. 10.1038/nature07767.PubMedPubMedCentral
131.
Suzuki T, Nakaya T: Regulation of amyloid beta-protein precursor by phosphorylation and protein interactions. J Biol Chem. 2008, 283 (44): 29633-7. 10.1074/jbc.R800003200.PubMedPubMedCentral
132.
Iijima K, et al: Neuron-specific phosphorylation of Alzheimer's beta-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem. 2000, 75 (3): 1085-91.PubMed
133.
Kimberly WT, et al: Physiological regulation of the beta-amyloid precursor protein signaling domain by c-Jun N-terminal kinase JNK3 during neuronal differentiation. J Neurosci. 2005, 25 (23): 5533-43. 10.1523/JNEUROSCI.4883-04.2005.PubMed
134.
Muresan Z, Muresan V: c-Jun NH2-terminal kinase-interacting protein-3 facilitates phosphorylation and controls localization of amyloid-beta precursor protein. J Neurosci. 2005, 25 (15): 3741-51. 10.1523/JNEUROSCI.0152-05.2005.PubMed
135.
Scheinfeld MH, et al: Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. J Biol Chem. 2003, 278 (43): 42058-63. 10.1074/jbc.M304853200.PubMed
136.
Ando K, et al: Role of phosphorylation of Alzheimer's amyloid precursor protein during neuronal differentiation. J Neurosci. 1999, 19 (11): 4421-7.PubMed
137.
Muresan Z, Muresan V: Coordinated transport of phosphorylated amyloid-beta precursor protein and c-Jun NH2-terminal kinase-interacting protein-1. J Cell Biol. 2005, 171 (4): 615-25. 10.1083/jcb.200502043.PubMedPubMedCentral
138.
Lee MS, et al: APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol. 2003, 163 (1): 83-95. 10.1083/jcb.200301115.PubMedPubMedCentral
139.
Ando K, et al: Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J Biol Chem. 2001, 276 (43): 40353-61.PubMed
140.
Tamayev R, Zhou D, D'Adamio L: The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener. 2009, 4: 28-10.1186/1750-1326-4-28.PubMedPubMedCentral
141.
Taru H, Suzuki T: Facilitation of stress-induced phosphorylation of beta-amyloid precursor protein family members by X11-like/Mint2 protein. J Biol Chem. 2004, 279 (20): 21628-36. 10.1074/jbc.M312007200.PubMed
142.
Pastorino L, et al: The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature. 2006, 440 (7083): 528-34. 10.1038/nature04543.PubMed
143.
Lu PJ, et al: The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 1999, 399 (6738): 784-8. 10.1038/21650.PubMed
144.
Sano Y, et al: Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP. PLoS One. 2006, 1: e51-10.1371/journal.pone.0000051.PubMedPubMedCentral
145.
Koo EH: The beta-amyloid precursor protein (APP) and Alzheimer's disease: does the tail wag the dog?. Traffic. 2002, 3 (11): 763-70. 10.1034/j.1600-0854.2002.31101.x.PubMed
146.
King GD, Turner SR: Adaptor protein interactions: modulators of amyloid precursor protein metabolism and Alzheimer's disease risk?. Exp Neurol. 2004, 185 (2): 208-19. 10.1016/j.expneurol.2003.10.011.PubMed
147.
Barbagallo AP, et al: Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo. PLoS One. 5 (11): e15503-
148.
Pietrzik CU, et al: FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J Neurosci. 2004, 24 (17): 4259-65. 10.1523/JNEUROSCI.5451-03.2004.PubMed
149.
Yankner BA, et al: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 1989, 245 (4916): 417-20. 10.1126/science.2474201.PubMed
150.
Oster-Granite ML, et al: Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J Neurosci. 1996, 16 (21): 6732-41.PubMed
151.
Neve RL, et al: Transgenic mice expressing APP-C100 in the brain. Neurobiol Aging. 1996, 17 (2): 191-203. 10.1016/0197-4580(95)02074-8.PubMed
152.
Cupers P, et al: The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J Neurochem. 2001, 78 (5): 1168-78. 10.1046/j.1471-4159.2001.00516.x.PubMed
153.
Kimberly WT, et al: The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem. 2001, 276 (43): 40288-92.PubMed
154.
Passer B, et al: Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis. 2000, 2 (3-4): 289-301.PubMed
155.
Kinoshita A, et al: The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem. 2002, 277 (32): 28530-6. 10.1074/jbc.M203372200.PubMed
156.
Chang KA, Suh YH: Possible roles of amyloid intracellular domain of amyloid precursor protein. BMB Rep. 43 (10): 656-63.
157.
Gao Y, Pimplikar SW: The gamma-secretase-cleaved C-terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad Sci USA. 2001, 98 (26): 14979-84. 10.1073/pnas.261463298.PubMedPubMedCentral
158.
Ryan KA, Pimplikar SW: Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol. 2005, 171 (2): 327-35. 10.1083/jcb.200505078. Epub 2005 Oct 17PubMedPubMedCentral
159.
Giliberto L, et al: Transgenic Expression of the Amyloid-beta Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease-Like Traits In Vivo. PLoS One. 5 (7): e11609-
160.
Ghosal K, et al: Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci USA. 2009, 106 (43): 18367-72. 10.1073/pnas.0907652106.PubMedPubMedCentral
161.
Lu DC, et al: A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med. 2000, 6 (4): 397-404. 10.1038/74656.PubMed
162.
Bertrand E, et al: A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol Cell Neurosci. 2001, 18 (5): 503-11. 10.1006/mcne.2001.1030.PubMed
163.
Galvan V, et al: Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA. 2006, 103 (18): 7130-5. 10.1073/pnas.0509695103. Epub 2006 Apr 25PubMedPubMedCentral
164.
Saganich MJ, et al: Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J Neurosci. 2006, 26 (52): 13428-36. 10.1523/JNEUROSCI.4180-06.2006.PubMed
165.
Park SA, et al: Mechanism of cytotoxicity mediated by the C31 fragment of the amyloid precursor protein. Biochem Biophys Res Commun. 2009, 388 (2): 450-5. 10.1016/j.bbrc.2009.08.042.PubMedPubMedCentral
166.
Harris JA, et al: Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci. 30 (1): 372-81.
167.
Bredesen DE, John V, Galvan V: Importance of the caspase cleavage site in amyloid-beta protein precursor. J Alzheimers Dis. 22 (1): 57-63.
168.
De Strooper B, Annaert W: Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu Rev Cell Dev Biol. 26: 235-60.
169.
Goodger ZV, et al: Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci. 2009, 122 (Pt 20): 3703-14.PubMed
170.
Sala Frigerio C, et al: beta-Secretase cleavage is not required for generation of the intracellular C-terminal domain of the amyloid precursor family of proteins. FEBS J. 277 (6): 1503-18.
171.
Cao X, Sudhof TC: A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science. 2001, 293 (5527): 115-20. 10.1126/science.1058783.PubMed
172.
Scheinfeld MH, Matsuda S, D'Adamio L: JNK-interacting protein-1 promotes transcription of A beta protein precursor but not A beta precursor-like proteins, mechanistically different than Fe65. Proc Natl Acad Sci USA. 2003, 100 (4): 1729-34. 10.1073/pnas.0437908100.PubMedPubMedCentral
173.
Cao X, Sudhof TC: Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation. J Biol Chem. 2004, 279 (23): 24601-11. 10.1074/jbc.M402248200. Epub 2004 Mar 24PubMed
174.
Hass MR, Yankner BA: A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein. J Biol Chem. 2005, 280 (44): 36895-904. 10.1074/jbc.M502861200. Epub 2005 Aug 15PubMedPubMedCentral
175.
Yang Z, et al: A dominant role for FE65 (APBB1) in nuclear signaling. J Biol Chem. 2006, 281 (7): 4207-14. 10.1074/jbc.M508445200. Epub 2005 Dec 6PubMed
176.
Giliberto L, et al: Evidence that the Amyloid beta Precursor Protein-intracellular domain lowers the stress threshold of neurons and has a "regulated" transcriptional role. Mol Neurodegener. 2008, 3: 12-10.1186/1750-1326-3-12.PubMedPubMedCentral
177.
Baek SH, et al: Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell. 2002, 110 (1): 55-67. 10.1016/S0092-8674(02)00809-7.PubMed
178.
Kim HS, et al: C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 2003, 17 (13): 1951-3.PubMed
179.
Pardossi-Piquard R, et al: Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron. 2005, 46 (4): 541-54. 10.1016/j.neuron.2005.04.008.PubMed
180.
Zhang YW, et al: Presenilin/gamma-secretase-dependent processing of beta-amyloid precursor protein regulates EGF receptor expression. Proc Natl Acad Sci USA. 2007, 104 (25): 10613-8. 10.1073/pnas.0703903104. Epub 2007 Jun 7PubMedPubMedCentral
181.
Checler F, et al: The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53. Current Alzheimer Research. 2007, 4 (4): 423-6. 10.2174/156720507781788945.PubMed
182.
Liu Q, et al: Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1. Neuron. 2007, 56 (1): 66-78. 10.1016/j.neuron.2007.08.008.PubMedPubMedCentral
183.
von Rotz RC, et al: The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci. 2004, 117 (Pt 19): 4435-48.PubMed
184.
Leissring MA, et al: A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP. Proc Natl Acad Sci USA. 2002, 99 (7): 4697-702. 10.1073/pnas.072033799.PubMedPubMedCentral
185.
Muller T, et al: Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell. 2007, 18 (1): 201-10.PubMedPubMedCentral
186.
Hebert SS, et al: Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep. 2006, 7 (7): 739-45. 10.1038/sj.embor.7400704. Epub 2006 May 19PubMedPubMedCentral
187.
Chen AC, Selkoe DJ: Response to: Pardossi-Piquard et al., "Presenilin-Dependent Transcriptional Control of the Abeta-Degrading Enzyme Neprilysin by Intracellular Domains of betaAPP and APLP." Neuron 46, 541-554. Neuron. 2007, 53 (4): 479-83. 10.1016/j.neuron.2007.01.023.PubMed
188.
Repetto E, et al: Presenilin 1 regulates epidermal growth factor receptor turnover and signaling in the endosomal-lysosomal pathway. Journal of Biological Chemistry. 2007, 282 (43): 31504-16. 10.1074/jbc.M704273200.PubMed
189.
Tamboli IY, et al: Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis. J Neurosci. 2008, 28 (46): 12097-106. 10.1523/JNEUROSCI.2635-08.2008.PubMed
190.
Waldron E, et al: Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription. Exp Cell Res. 2008, 314 (13): 2419-33. 10.1016/j.yexcr.2008.05.003.PubMed
191.
Hornsten A, et al: APL-1, a Caenorhabditis elegans protein related to the human beta-amyloid precursor protein, is essential for viability. Proc Natl Acad Sci USA. 2007, 104 (6): 1971-6. 10.1073/pnas.0603997104. Epub 2007 Jan 31PubMedPubMedCentral
192.
Wiese M, Antebi A, Zheng H: Intracellular trafficking and synaptic function of APL-1 in Caenorhabditis elegans. PLoS One. 5 (9):
193.
Li H, et al: Genetic dissection of the amyloid precursor protein in developmental function and amyloid pathogenesis. J Biol Chem. 285 (40): 30598-605.
194.
Gunawardena S, Goldstein LS: Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron. 2001, 32 (3): 389-401. 10.1016/S0896-6273(01)00496-2.PubMed
195.
Torroja L, et al: Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport. Curr Biol. 1999, 9 (9): 489-92. 10.1016/S0960-9822(99)80215-2.PubMed
196.
Kamal A, et al: Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature. 2001, 414 (6864): 643-8. 10.1038/414643a.PubMed
197.
Satpute-Krishnan P, DeGiorgis JA, Bearer EL: Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of alzheimer's disease. Aging Cell. 2003, 2 (6): 305-18. 10.1046/j.1474-9728.2003.00069.x.PubMedPubMedCentral
198.
Satpute-Krishnan P, et al: A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc Natl Acad Sci USA. 2006, 103 (44): 16532-7. 10.1073/pnas.0607527103. Epub 2006 Oct 24PubMedPubMedCentral
199.
Lazarov O, et al: Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci. 2005, 25 (9): 2386-95. 10.1523/JNEUROSCI.3089-04.2005.PubMed
200.
Torroja L, Luo L, White K: APPL, the Drosophila member of the APP-family, exhibits differential trafficking and processing in CNS neurons. J Neurosci. 1996, 16 (15): 4638-50.PubMed
201.
Ashley J, et al: Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint. J Neurosci. 2005, 25 (25): 5943-55. 10.1523/JNEUROSCI.1144-05.2005.PubMed
202.
Fossgreen A, et al: Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. Proc Natl Acad Sci USA. 1998, 95 (23): 13703-8. 10.1073/pnas.95.23.13703.PubMedPubMedCentral
203.
Merdes G, et al: Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila. Embo J. 2004, 23 (20): 4082-95. 10.1038/sj.emboj.7600413.PubMedPubMedCentral
204.
Muller U, et al: Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene. Cell. 1994, 79 (5): 755-65. 10.1016/0092-8674(94)90066-3.PubMed
205.
Zheng H, et al: beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell. 1995, 81 (4): 525-31. 10.1016/0092-8674(95)90073-X.PubMed
206.
Li ZW, et al: Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc Natl Acad Sci USA. 1996, 93 (12): 6158-62. 10.1073/pnas.93.12.6158.PubMedPubMedCentral
207.
Ring S, et al: The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci. 2007, 27 (29): 7817-26. 10.1523/JNEUROSCI.1026-07.2007.PubMed
208.
Magara F, et al: Genetic background changes the pattern of forebrain commissure defects in transgenic mice underexpressing the beta-amyloid-precursor protein. Proc Natl Acad Sci USA. 1999, 96 (8): 4656-61. 10.1073/pnas.96.8.4656.PubMedPubMedCentral
209.
Steinbach JP, et al: Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ. 1998, 5 (10): 858-66. 10.1038/sj.cdd.4400391.PubMed
210.
Phinney AL, et al: No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice. Neuroscience. 1999, 90 (4): 1207-16. 10.1016/S0306-4522(98)00645-9.PubMed
211.
Priller C, et al: Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci. 2006, 26 (27): 7212-21. 10.1523/JNEUROSCI.1450-06.2006.PubMed
212.
Bittner T, et al: Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J Neurosci. 2009, 29 (33): 10405-9. 10.1523/JNEUROSCI.2288-09.2009.PubMed
213.
Lee KJ, et al: Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines. Neuroscience. 169 (1): 344-56.
214.
Dawson GR, et al: Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience. 1999, 90 (1): 1-13. 10.1016/S0306-4522(98)00410-2.PubMed
215.
Seabrook GR, et al: Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology. 1999, 38 (3): 349-59. 10.1016/S0028-3908(98)00204-4.PubMed
216.
Yang L, et al: Amyloid precursor protein regulates Cav1.2 L-type calcium channel levels and function to influence GABAergic short-term plasticity. J Neurosci. 2009, 29 (50): 15660-8. 10.1523/JNEUROSCI.4104-09.2009.PubMedPubMedCentral
217.
Santos SF, et al: Expression of human amyloid precursor protein in rat cortical neurons inhibits calcium oscillations. J Neurosci. 2009, 29 (15): 4708-18. 10.1523/JNEUROSCI.4917-08.2009.PubMed
218.
Yang L, et al: Increased asynchronous release and aberrant calcium channel activation in amyloid precursor protein deficient neuromuscular synapses. Neuroscience. 2007, 149 (4): 768-78. 10.1016/j.neuroscience.2007.08.025. Epub 2007 Aug 28PubMedPubMedCentral
219.
von Koch CS, et al: Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol Aging. 1997, 18 (6): 661-9. 10.1016/S0197-4580(97)00151-6.PubMed
220.
Heber S, et al: Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci. 2000, 20 (21): 7951-63.PubMed
221.
Wang P, et al: Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci. 2005, 25 (5): 1219-25. 10.1523/JNEUROSCI.4660-04.2005.PubMed
222.
Yang G, et al: Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci Lett. 2005, 384 (1-2): 66-71. 10.1016/j.neulet.2005.04.040.PubMed
223.
Wang B, et al: Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proc Natl Acad Sci USA. 2007, 104: 14140-14145. 10.1073/pnas.0704070104.PubMedPubMedCentral
224.
Herms J, et al: Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. Embo J. 2004, 23 (20): 4106-15. 10.1038/sj.emboj.7600390.PubMedPubMedCentral
225.
Guenette S, et al: Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. Embo J. 2006, 25 (2): 420-31. 10.1038/sj.emboj.7600926. Epub 2006 Jan 12PubMedPubMedCentral
226.
Lambert de Rouvroit C, Goffinet AM: Neuronal migration. Mech Dev. 2001, 105 (1-2): 47-56. 10.1016/S0925-4773(01)00396-3.PubMed
227.
Ring S, et al: The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci. 2007, 27 (29): 7817-26. 10.1523/JNEUROSCI.1026-07.2007.PubMed
228.
Barbagallo AP, et al: A single tyrosine residue in the amyloid precursor protein intracellular domain is essential for developmental function. J Biol Chem.
Metadata
Title
Biology and pathophysiology of the amyloid precursor protein
Authors
Hui Zheng
Edward H Koo
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Molecular Neurodegeneration / Issue 1/2011
Electronic ISSN: 1750-1326
DOI
https://doi.org/10.1186/1750-1326-6-27

Other articles of this Issue 1/2011

Molecular Neurodegeneration 1/2011 Go to the issue

Research article

Generation and characterization of transgenic mice expressing mitochondrial targeted red fluorescent protein selectively in neurons: modeling mitochondriopathy in excitotoxicity and amyotrophic lateral sclerosis

Research article

Tyrosine Phosphorylation of Tau by the Src Family Kinases Lck and Fyn

Research article

Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration

Short report

Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function

Research article

Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2/Shank3 scaffold

Research article

A Wnt1 regulated Frizzled-1/β-Cateninsignaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection